pH-triggered drug release from biodegradable microwells for oral drug delivery.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
AuthorsNielsen, Line Hagner
Keller, Stephan Sylvest
MetadataShow full item record
AbstractMicrowells fabricated from poly-L-lactic acid (PLLA) were evaluated for their application as an oral drug delivery system using the amorphous sodium salt of furosemide (ASSF) as a model drug. Hot embossing of PLLA resulted in fabrication of microwells with an inner diameter of 240 μm and a height of 100 μm. The microwells were filled with ASSF using a modified screen printing technique, followed by coating of the microwell cavities with a gastro-resistant lid of Eudragit® L100. The release behavior of ASSF from the coated microwells was investigated using a μ-Diss profiler and a UV imaging system, and under conditions simulating the changing environment of the gastrointestinal tract. Biorelevant gastric medium (pH 1.6) was employed, after which a change to biorelevant intestinal release medium (pH 6.5) was carried out. Both μ-Diss profiler and UV imaging release experiments showed that sealing of microwell cavities with an Eudragit® layer prevented drug release in biorelevant gastric medium. An immediate release of the ASSF from coated microwells was observed in the intestinal medium. This pH-triggered release behavior demonstrates the future potential of PLLA microwells as a site-specific oral drug delivery system.
CitationpH-triggered drug release from biodegradable microwells for oral drug delivery. 2015, 17 (3):9958 Biomed Microdevices
The following license files are associated with this item:
- Polymeric microcontainers improve oral bioavailability of furosemide.
- Authors: Nielsen LH, Melero A, Keller SS, Jacobsen J, Garrigues T, Rades T, Müllertz A, Boisen A
- Issue date: 2016 May 17
- Development of chitosan and polylactic acid based methotrexate intravitreal micro-implants to treat primary intraocular lymphoma: an in vitro study.
- Authors: Manna S, Augsburger JJ, Correa ZM, Landero JA, Banerjee RK
- Issue date: 2014 Feb
- Evaluation of in vitro drug release, pH change, and molecular weight degradation of poly(L-lactic acid) and poly(D,L-lactide-co-glycolide) fibers.
- Authors: Crow BB, Borneman AF, Hawkins DL, Smith GM, Nelson KD
- Issue date: 2005 Jul-Aug
- [Fabrication, characterization and drug release characteristics of drug loaded poly (L-lactic acid) fiber].
- Authors: Gao H, Ping Q, Gu Y
- Issue date: 2008 Aug
- Stabilisation of amorphous furosemide increases the oral drug bioavailability in rats.
- Authors: Nielsen LH, Rades T, Müllertz A
- Issue date: 2015 Jul 25